Oncalis AG Licenses PI3K Inhibitors From ChemDiv Inc.
SCHLIEREN, Switzerland, LAUSANNE, Switzerland and SAN DIEGO, October 6 /PRNewswire/ --
Oncalis AG (Oncalis), a privately-owned Swiss biotechnology company, and ChemDiv Inc. (ChemDiv), a privately-…